Target intelligence / Profile preview

Immunoglobulin lambda variable 3-25 (IGLV3-25)

Target
IGLV3-25
Molecular classification
Immunoglobulin variable region gene, Antibody gene segment, Other (as it does not fit into typical receptor/enzyme families)
01

Overview

Immunoglobulin lambda variable 3-25 is a human gene segment encoding one of the variable regions (V regions) of the lambda chain of immunoglobulins (antibodies). This segment, IGLV3-25, contributes to generating the vast diversity of antibodies through somatic recombination with other immunoglobulin gene segments in B cells. The variable (V) regions encode the antigen-binding domain of antibodies, allowing for specific antigen recognition crucial to adaptive immunity. IGLV3-25 is one of several functional IGLV3 subgroup genes located on chromosome 22 and is involved in the normal immune repertoire. It is not a classical "therapeutic target" (like a receptor or enzyme); rather, it is a genetic component of endogenous antibodies, although its usage or mutation profile can serve as a marker in some hematological malignancies[2][1].

Other names
IGLV3-25Ig lambda chain V-IV region HilIGLV325V2-17Ig lambda chain V-IV region Hil (note: may be a repeated or descriptive synonym)
02

Biological functions

Antigen recognitionAdaptive immune response
03

Disease associations

Cancer (e.g., multiple myeloma, B-cell malignancies: abnormal clonal expansion/use of immunoglobulin gene segments)Other (as a component of the immune system, broadly linked to immune disorders)
04

Biomarkers

Clonality markers in B-cell malignancies (e.g., identification of monoclonal B-cell populations via V region usage in lymphoma/leukemia diagnostics)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-25 (IGLV3-25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-25 (IGLV3-25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call